TRX-818 - CAS# 1256037-58-7 039 it was shown and used

it was shown and used to enhance the survival and cloning efficiency of many primary cell types after single cell dissociation without affecting their self-renewal properties

MLN8237 was dosed to mice orally at 15-30 mg/kg once per day

R-(+)-ETOMOXIR

CFTR Inhibitor 172

TRX-818 - CAS# 1256037-58-7 039 it was shown and usedTRX 818, also known as Foslinanib, CVM 1118, CAS No. 1256037 58 7, is an orally bioavailable agent with potential antineoplastic and anti vasculogenic mimicry (VM) activities. Although the exact multiple mechanisms of action through which this agent exerts its effects have yet to be fully elucidated, TRX 818, upon oral administration appears to induce cancer cell apoptosis and inhibits cancer cell proliferation. This agent also prevents tumor cell VM